1. Lee HH, Gwillim E, Patel KR, et al. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol 2020; 82: 675-82.
2.
Sterkens A, Lambert J, Bervoets A. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options. Clin Exp Med 2021; 21: 215-30.
3.
Trüeb RM, Dias MFRG. Alopecia areata: a comprehensive review of pathogenesis and management. Clin Rev Allergy Immunol 2018; 54: 68-87.
4.
Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 2018; 78: 1-12.
5.
Chelidze K, Lipner SR. Nail changes in alopecia areata: an update and review. Int J Dermatol 2018; 57: 776-83.
6.
Mostaghimi A, Napatalung L, Sikirica V, et al. Patient perspectives of the social, emotional and functional impact of alopecia areata: a systematic literature review. Dermatol Ther (Heidelb) 2021; 11: 867-83.
7.
Kacar SD, Soyucok E, Bagcioglu E, et al. The perceived stigma in patients with alopecia and mental disorder: a comparative study. Int J Trichology 2016; 8: 135-40.
8.
Creadore A, Manjaly P, Li SJ, et al. Evaluation of stigma toward individuals with alopecia. JAMA Dermatol 2021; 157: 392-8.
9.
Gandhi K, Shy ME, Ray M, et al. The association of alopecia areata-related emotional symptoms with work productivity and daily activity among patients with alopecia areata. Dermatol Ther (Heidelb) 2023; 13: 285-98.
10.
Toussi A, Barton VR, Le ST, et al. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. J Am Acad Dermatol 2021; 85: 162-75.
11.
Szepietowski JC, Reich A, Wesołowska-Szepietowska E, et al.; National Quality of Life in Dermatology Group. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses 2009; 52: 357-63.
12.
Chernyshov PV. The evolution of quality of life assessment and use in dermatology. Dermatology 2019; 235: 167-74.
13.
Chen SC, Yeung J, Chren MM. Scalpdex: a quality-of-life instrument for scalp dermatitis. Arch Dermatol 2002; 138: 803-7.
14.
Fischer TW, Schmidt S, Strauss B, et al. Hairdex. Ein Instrument zur Untersuchung der krankheitsbezogenen Lebensqualität bei Patienten mit Haarerkrankungen [Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases]. Hautarzt 2001; 52: 219-27.
15.
Fabbrocini G, Panariello L, De Vita V, et al. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol 2013; 27: 276-81.
16.
King BA, Mesinkovska NA, Craiglow B, et al. Development of the alopecia areata scale for clinical use: results of an academic-industry collaborative effort. J Am Acad Dermatol 2022; 86: 359-64.
17.
Waśkiel A, Rakowska A, Sikora M, et al. Trichoscopy of alopecia areata: an update. J Dermatol 2018; 45: 692-700.
18.
Szepietowski J, Salomon J, Finlay AY, et al. Wskaźnik wpływu dolegliwości skórnych na jakość życia – Dermatology Life Quality Index (DLQI): polska wersja językowa. Dermatol Klin 2004; 6: 63-70.
19.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
20.
Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-8.
21.
Sterkens A, Lambert J, Bervoets A. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options. Clin Exp Med 2021; 21: 215-30.
22.
Mesinkovska N, Craiglow B, Ball SG, et al. The invisible impact of a visible disease: psychosocial impact of alopecia areata. Dermatol Ther (Heidelb) 2023; 13: 1503-15.
23.
Marahatta S, Agrawal S, Adhikari BR. Psychological impact of alopecia areata. Dermatol Res Pract 2020; 2020: 8879343.
24.
Alzubaidy BA, Banjar TA, Almaghrabi MA, et al. Evaluation of the awareness, beliefs, and psychological impact of patients with alopecia areata in Makkah City, Saudi Arabia. Adv Med 2023; 2023: 4286891.
25.
Aldhouse NVJ, Kitchen H, Knight S, et al. “’You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes 2020; 4: 76.
26.
Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 921-8.
27.
Güleç AT, Tanriverdi N, Dürü C, et al. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004; 43: 352-6.
28.
Mulinari-Brenner F. Psychosomatic aspects of alopecia areata. Clin Dermatol 2018; 36: 709-13.
29.
Nasimi M, Ghandi N, Torabzade L, et al. Alopecia Areata-Quality of Life Index Questionnaire (Reliability and Validity of the Persian Version) in comparison to Dermatology Life Quality Index. Int J Trichology 2020; 12: 227-33.
